Stryker (NYSE:SYK) shares dipped after hours today despite second-quarter results that topped the consensus forecast. The Kalamazoo, Mich.-based company posted profits of $592 million, or $1.55 per share, on sales of $4.3 billion for the three months ended June 30, 2021, marking a massive bottom-line gain from losses of $83 million this time last year […]
Wall Street Beat
NeuroMetrix stock slides on publication of Quell study
NeuroMetrix (NSDQ:NURO) stock is hitting a massive skid this week after the publication of a study on its Quell non-invasive nerve stimulation device for pain relief. Shares of NURO were down -12.2% at $18.41 apiece by late-afternoon trading yesterday on the news. The stock continues to decline today, down –7.1% to $16.94 per share by […]
GE beats The Street as healthcare segment thrives in Q2
GE (NYSE:GE) shares ticked up today on second-quarter results that beat the consensus forecast. The Boston-based company’s healthcare segment posted profits of $801 million, registering a bottom-line gain of 58.3% year-over-year on sales of $4.5 billion — a 14% increase on revenues from the previous year. GE’s overall sales totaled $18.3 billion for the three […]
3M’s healthcare segment registers growth in Street-beating Q2
3M (NYSE:MMM) reported second-quarter results that beat the consensus forecast — with the company’s healthcare segment showing especially robust growth. The St. Paul, Minn.–based company posted profits of $1.5 billion, or $2.59 per share, on sales of $9 billion for the three months ended June 30, 2021, for a 16.7% bottom-line gain on sales growth […]
Boston Scientific rises on Street-beating Q2
Boston Scientific (NYSE:BSX) shares are up today on second-quarter results that topped the consensus forecast. The Marlborough, Mass.-based company posted profits of $172 million, or 12¢ per share, on sales of $3.1 billion for the three months ended June 30, 2021, marking a massive bottom-line gain from losses of $153 million this time last year. […]
MedTech 100 roundup: Return to normal after last week’s spike
After rising more than 31 points to heights never before reached, the medtech industry returned to normal this past week. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 23) at 115.54 points, a total that, had it not been for the previous week, would […]
NeuroMetrix’s Q2 earnings report sends its stock to new heights
NeuroMetrix (NSDQ:NURO) shares saw a huge boost this today on strong second-quarter revenues and an increased bottom line. NURO shares were up 19.1% at $24.77 per share in mid-afternoon trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 0.4%. The Woburn, Mass.-based company posted losses […]
Danaher rises on Street-beating Q2
Danaher (NYSE:DHR) shares ticked up today on second-quarter results that beat the consensus forecast. The Washington, D.C.–based company posted profits of $1.7 billion, or $2.40 per share, on sales of $7.2 billion for the three months ended July 2, 2021, for a 95.5% bottom-line gain on sales growth of 36.3%. Adjusted to exclude one-time items, […]
COVID-19 testing boosts Abbott in Street-beating Q2
Abbott (NYSE:ABT) shares took a small dip despite second-quarter results that topped the consensus forecast. The Abbott Park, Ill.-based company posted profits of $1.2 billion, or 66¢ per share, on sales of $10.2 billion for the three months ended June 30, 2021, for a more-than doubled bottom-line on sales growth of 39.5%. Adjusted to exclude […]
Intuitive Surgical dips despite Street-beating Q2
Intuitive Surgical (NSDQ:ISRG) shares hit a small skid this morning on second-quarter results that topped the consensus forecast. The Sunnyvale, Calif.–based robotic surgery company posted profits of $517.2 million, or $4.25 per share, on sales of $1.5 billion for the three months ended June 30, 2021, multiplying its bottom line by nearly seven times on […]
J&J beats The Street in Q2, raises guidance
An accelerated rebound in medical device sales helped drive Johnson & Johnson (NYSE:JNJ) second-quarter results that topped the consensus forecast. The New Brunswick, N.J.-based company posted profits of $6.3 billion, or $2.35 per share, on sales of $23.3 billion for the three months ended June 30, 2021, for a 73.1% bottom-line gain on sales growth […]
